This company has been acquired
Societal CDMO Future Growth
Future criteria checks 1/6
Societal CDMO is forecast to grow revenue at 8.3% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 17.4% |
Revenue growth rate | 8.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 08 Apr 2024 |
Recent future growth updates
Recent updates
Societal CDMO, Inc.'s (NASDAQ:SCTL) Price Is Right But Growth Is Lacking After Shares Rocket 38%
Feb 10Is There An Opportunity With Societal CDMO, Inc.'s (NASDAQ:SCTL) 46% Undervaluation?
Feb 02Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?
Dec 23Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?
May 31Societal CDMO signs two CDMO service agreements
Oct 20Societal stock soars 20% on signing 2 manufacturing contracts
Sep 07Societal CDMO estimates to receive up to $50M on real estates' sales
Aug 16Societal CDMO, Lannett amend license and supply deal
Jul 12These 4 Measures Indicate That Societal CDMO (NASDAQ:SCTL) Is Using Debt Extensively
Apr 29Is Recro Pharma (NASDAQ:REPH) A Risky Investment?
Jan 06Recro Pharma jumps 15% on Q1 result estimates beat
May 07Would Shareholders Who Purchased Recro Pharma's (NASDAQ:REPH) Stock Year Be Happy With The Share price Today?
Feb 15Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 111 | N/A | 13 | N/A | 1 |
12/31/2025 | 101 | N/A | 7 | N/A | 1 |
12/31/2024 | 95 | -9 | 0 | N/A | 2 |
12/31/2023 | 95 | -13 | -9 | -1 | N/A |
9/30/2023 | 91 | -22 | -11 | -1 | N/A |
6/30/2023 | 89 | -20 | -10 | 1 | N/A |
3/31/2023 | 91 | -20 | -8 | 2 | N/A |
12/31/2022 | 90 | -20 | -12 | -4 | N/A |
9/30/2022 | 88 | -13 | -9 | -1 | N/A |
6/30/2022 | 85 | -13 | -4 | 2 | N/A |
3/31/2022 | 80 | -9 | -3 | 3 | N/A |
12/31/2021 | 75 | -11 | 6 | 11 | N/A |
9/30/2021 | 63 | -21 | 4 | 9 | N/A |
6/30/2021 | 64 | -19 | 0 | 8 | N/A |
3/31/2021 | 62 | -27 | -3 | 6 | N/A |
12/31/2020 | 66 | -28 | 0 | 8 | N/A |
9/30/2020 | 74 | -21 | -3 | 3 | N/A |
6/30/2020 | 80 | -14 | 2 | 6 | N/A |
3/31/2020 | 96 | -3 | -17 | -11 | N/A |
12/31/2019 | 99 | 5 | -34 | -25 | N/A |
9/30/2019 | 99 | 35 | -42 | -31 | N/A |
6/30/2019 | 92 | 17 | -58 | -47 | N/A |
3/31/2019 | 83 | 0 | -49 | -41 | N/A |
12/31/2018 | 77 | -13 | -50 | -43 | N/A |
9/30/2018 | 79 | -63 | -40 | -34 | N/A |
6/30/2018 | 77 | -58 | -37 | -30 | N/A |
3/31/2018 | 73 | -54 | -31 | -25 | N/A |
12/31/2017 | 72 | -7 | -22 | -17 | N/A |
9/30/2017 | 70 | -36 | N/A | -17 | N/A |
6/30/2017 | 70 | -33 | N/A | -9 | N/A |
3/31/2017 | 70 | -32 | N/A | -8 | N/A |
12/31/2016 | 69 | -30 | N/A | -3 | N/A |
9/30/2016 | 69 | -9 | N/A | -4 | N/A |
6/30/2016 | 68 | -6 | N/A | 1 | N/A |
3/31/2016 | 70 | 1 | N/A | 9 | N/A |
12/31/2015 | 52 | 3 | N/A | 8 | N/A |
9/30/2015 | 35 | -11 | N/A | 4 | N/A |
6/30/2015 | 19 | -14 | N/A | -6 | N/A |
3/31/2015 | N/A | -15 | N/A | -13 | N/A |
12/31/2014 | N/A | -17 | N/A | -11 | N/A |
9/30/2014 | N/A | -14 | N/A | -7 | N/A |
6/30/2014 | N/A | -10 | N/A | -3 | N/A |
3/31/2014 | N/A | -8 | N/A | -2 | N/A |
12/31/2013 | N/A | -2 | N/A | -1 | N/A |
9/30/2013 | N/A | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SCTL's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if SCTL's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if SCTL's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SCTL's revenue (8.3% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: SCTL's revenue (8.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SCTL's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/04/08 13:44 |
End of Day Share Price | 2024/04/08 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Societal CDMO, Inc. is covered by 15 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Difei Yang | Aegis Capital Corporation |
Patrick Trucchio | Berenberg |
Jonathan Aschoff | Brean Capital |